Abbott (ABT) Tops Q2 EPS by 3c; offers guidance
Tweet
Share
E-mail
Get Alerts ABT Hot Sheet
Price: $108.33 -0.42%
Revenue Growth %: +14.2%
Financial Fact:
Diluted Earnings Per Common Share (in dollars per share): -0.22
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +14.2%
Financial Fact:
Diluted Earnings Per Common Share (in dollars per share): -0.22
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Abbott (NYSE: ABT) reported Q2 EPS of $1.31, $0.03 better than the analyst estimate of $1.28. Revenue for the quarter came in at $12.59 billion versus the consensus estimate of $12.52 billion.
GUIDANCE:
Abbott sees FY2026 EPS of $5.45-$5.60, versus the consensus of $5.48.
For earnings history and earnings-related data on Abbott (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- JPMorgan Starts Bytes Technology Group PLC (BYIT:LN) at Underweight
- Jefferies Downgrades Xior Student Housing NV (XIOR:BB) to Hold
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
